Discover
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Bispecific Antibodies in Myeloma: Approvals and Clinical Trials

Bispecific Antibodies in Myeloma: Approvals and Clinical Trials
Update: 2024-05-31
Share
Description
Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.
Comments
In Channel



